ENDRA LIFE SCIENCES INC. Net Fee Amt
ENDRA LIFE SCIENCES INC. (NDRA) had Net Fee Amt of $2.22 thousand as of 2026-03-30, per its S-8 filed 2026-05-15.
Financial Statements › Notes
ffd:NetFeeAmt · last filed 2026-05-15
- 2026-03-30: Net Fee Amt $2.22K.
| Period end | Net Fee Amt |
|---|---|
| 2026-03-30 | $2.22K S-8 · filed 2026-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |